Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

The Ohio AG’s office claims that GSK and its predecessor company hit an internal study in 1982 that showed Zantac can break ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Me is potentially selling more than just your genetic data—the personal survey info it collected is just as much a privacy ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Shares of several companies, including Asian Paints, Indus Towers, and Gujarat Gas, among others, will be in the news today ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

In March, the Prime Minister Keir Starmer announced plans to scrap NHS England, the public body that oversees the National ...

GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have agreed to dismiss a U.S. patent lawsuit over Pfizers RSV vaccine, ...

If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...